LAUREN SMALL: Open Payments
NPI 1194284117 · BENNETSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 17 payments from 10 companies in 2025. Trend: 2023 $510 · 2024 $143 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 4 | $302 |
| Novo Nordisk Inc | 4 | $137 |
| PFIZER INC. | 2 | $32 |
| Abbott Laboratories | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: Xeomin, Ozempic, FREESTYLE LIBRE 3, Qelbree, INJECTAFER, GEMTESA, SHINGRIX, PREVNAR 20.
Industry payments across SC — which companies pay providers there.
